Drug Maker Krka 207th R&D Investor in EU

Brussels, 18 October - Investing EUR 90.92m in research and development in 2010, Slovenian drug maker Krka took 207th place on the list of 1,000 biggest R&D investors in the EU, according to a report of the European Commission presented on Tuesday. Krka's investment in R&D increased by EUR 2.6m in 2010 compared to the year before.

The rest of this news item is available to subscribers.
The news item consists of 623 characters (without spaces) or 131 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

© STA, 2011